Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Kwesi-Maliepaard EM"'
Autor:
Kwesi-Maliepaard EM; Division of Gene Regulation, Netherlands Cancer Institute, Amsterdam, Netherlands., Malik M; Division of Gene Regulation, Netherlands Cancer Institute, Amsterdam, Netherlands., van Welsem T; Division of Gene Regulation, Netherlands Cancer Institute, Amsterdam, Netherlands., van Doorn R; Department of Dermatology, Leiden University Medical Center, Leiden, Netherlands., Vermeer MH; Department of Dermatology, Leiden University Medical Center, Leiden, Netherlands., Vlaming H; Division of Gene Regulation, Netherlands Cancer Institute, Amsterdam, Netherlands., Jacobs H; Division of Tumor Biology and Immunology, Netherlands Cancer Institute, Amsterdam, Netherlands., van Leeuwen F; Division of Gene Regulation, Netherlands Cancer Institute, Amsterdam, Netherlands.; Department of Medical Biology, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.
Publikováno v:
Frontiers in genetics [Front Genet] 2022 Nov 08; Vol. 13, pp. 1032958. Date of Electronic Publication: 2022 Nov 08 (Print Publication: 2022).
Autor:
Molenaar TM; Division of Gene Regulation, Netherlands Cancer Institute, 1066CX Amsterdam, The Netherlands., Malik M; Division of Gene Regulation, Netherlands Cancer Institute, 1066CX Amsterdam, The Netherlands., Silva J; Division of Oncogenomics, Netherlands Cancer Institute, 1066CX Amsterdam, The Netherlands., Liu NQ; Division of Gene Regulation, Oncode Institute, Netherlands Cancer Institute, 1066CX Amsterdam, The Netherlands., Haarhuis JHI; Division of Cell Biology, Netherlands Cancer Institute, 1066CX Amsterdam, The Netherlands., Ambrosi C; Department of Molecular Mechanisms of Disease, University of Zurich, 8057 Zurich, Switzerland.; Life Science Zurich Graduate School, University of Zurich and ETH Zurich, CH-8057 Zurich, Switzerland., Kwesi-Maliepaard EM; Division of Gene Regulation, Netherlands Cancer Institute, 1066CX Amsterdam, The Netherlands., van Welsem T; Division of Gene Regulation, Netherlands Cancer Institute, 1066CX Amsterdam, The Netherlands., Baubec T; Department of Molecular Mechanisms of Disease, University of Zurich, 8057 Zurich, Switzerland.; Genome Biology and Epigenetics, Institute of Biodynamics and Biocomplexity, Department of Biology, Utrecht University, 3584 CH Utrecht, The Netherlands., Faller WJ; Division of Oncogenomics, Netherlands Cancer Institute, 1066CX Amsterdam, The Netherlands., van Leeuwen F; Division of Gene Regulation, Netherlands Cancer Institute, 1066CX Amsterdam, The Netherlands.; Department of Medical Biology, Amsterdam UMC, University of Amsterdam, 1105AZ Amsterdam, The Netherlands.
Publikováno v:
Journal of cell science [J Cell Sci] 2022 Oct 01; Vol. 135 (19). Date of Electronic Publication: 2022 Oct 06.
Autor:
Kwesi-Maliepaard EM; Division of Gene Regulation, Netherlands Cancer Institute, 1066CX, Amsterdam, The Netherlands., Jacobs H; Division of Tumor Biology and Immunology, Netherlands Cancer Institute, 1066CX, Amsterdam, The Netherlands., van Leeuwen F; Division of Gene Regulation, Netherlands Cancer Institute, 1066CX, Amsterdam, The Netherlands. fred.v.leeuwen@nki.nl.; Department of Medical Biology, Amsterdam UMC, University of Amsterdam, 1105AZ, Amsterdam, The Netherlands. fred.v.leeuwen@nki.nl.
Publikováno v:
Cellular and molecular life sciences : CMLS [Cell Mol Life Sci] 2021 Oct; Vol. 78 (19-20), pp. 6395-6408. Date of Electronic Publication: 2021 Aug 16.
Autor:
Aslam MA; Division of Tumor Biology and Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Institute of Molecular Biology and Biotechnology, Bahauddin Zakariya University, Multan, Pakistan., Alemdehy MF; Division of Tumor Biology and Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Kwesi-Maliepaard EM; Division of Gene Regulation, Netherlands Cancer Institute, Amsterdam, The Netherlands., Muhaimin FI; Division of Tumor Biology and Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Caganova M; Max-Delbrück-Center for Molecular Medicine, Berlin, Germany., Pardieck IN; Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, The Netherlands., van den Brand T; Division of Gene Regulation, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Division of Gene Regulation, Oncode Institute, Netherlands Cancer Institute, Amsterdam, The Netherlands., van Welsem T; Division of Gene Regulation, Netherlands Cancer Institute, Amsterdam, The Netherlands., de Rink I; Genome Core Facility, Netherlands Cancer Institute, Amsterdam, The Netherlands., Song JY; Division of Experimental Animal Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands., de Wit E; Division of Gene Regulation, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Division of Gene Regulation, Oncode Institute, Netherlands Cancer Institute, Amsterdam, The Netherlands., Arens R; Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, The Netherlands., Jacobs H; Division of Tumor Biology and Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands., van Leeuwen F; Division of Gene Regulation, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Medical Biology, Amsterdam UMC, Location AMC, University of Amsterdam, Amsterdam, The Netherlands.
Publikováno v:
EMBO reports [EMBO Rep] 2021 Feb 03; Vol. 22 (2), pp. e51184. Date of Electronic Publication: 2021 Jan 07.
Autor:
Kwesi-Maliepaard EM; Division of Gene Regulation, Netherlands Cancer Institute, 1066CX Amsterdam, The Netherlands., Aslam MA; Division of Tumor Biology and Immunology, Netherlands Cancer Institute, 1066CX Amsterdam, The Netherlands.; Institute of Molecular Biology and Biotechnology, Bahauddin Zakariya University, 60800 Multan, Pakistan., Alemdehy MF; Division of Tumor Biology and Immunology, Netherlands Cancer Institute, 1066CX Amsterdam, The Netherlands., van den Brand T; Division of Gene Regulation, Oncode Institute, Netherlands Cancer Institute, 1066CX Amsterdam, The Netherlands., McLean C; Division of Gene Regulation, Netherlands Cancer Institute, 1066CX Amsterdam, The Netherlands., Vlaming H; Division of Gene Regulation, Netherlands Cancer Institute, 1066CX Amsterdam, The Netherlands., van Welsem T; Division of Gene Regulation, Netherlands Cancer Institute, 1066CX Amsterdam, The Netherlands., Korthout T; Division of Gene Regulation, Netherlands Cancer Institute, 1066CX Amsterdam, The Netherlands., Lancini C; Division of Gene Regulation, Netherlands Cancer Institute, 1066CX Amsterdam, The Netherlands., Hendriks S; Division of Gene Regulation, Netherlands Cancer Institute, 1066CX Amsterdam, The Netherlands., Ahrends T; Division of Tumor Biology and Immunology, Oncode Institute, Netherlands Cancer Institute, 1066CX Amsterdam, The Netherlands., van Dinther D; Department of Molecular Cell Biology and Immunology, Amsterdam University Medical Center (UMC), Vrije Universiteit Amsterdam, 1081HV Amsterdam, The Netherlands., den Haan JMM; Department of Molecular Cell Biology and Immunology, Amsterdam University Medical Center (UMC), Vrije Universiteit Amsterdam, 1081HV Amsterdam, The Netherlands., Borst J; Division of Tumor Biology and Immunology, Oncode Institute, Netherlands Cancer Institute, 1066CX Amsterdam, The Netherlands., de Wit E; Division of Gene Regulation, Oncode Institute, Netherlands Cancer Institute, 1066CX Amsterdam, The Netherlands., van Leeuwen F; Division of Gene Regulation, Netherlands Cancer Institute, 1066CX Amsterdam, The Netherlands; fred.v.leeuwen@nki.nl h.jacobs@nki.nl.; Department of Medical Biology, Amsterdam UMC, University of Amsterdam, 1105AZ Amsterdam, The Netherlands., Jacobs H; Division of Tumor Biology and Immunology, Netherlands Cancer Institute, 1066CX Amsterdam, The Netherlands; fred.v.leeuwen@nki.nl h.jacobs@nki.nl.
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2020 Aug 25; Vol. 117 (34), pp. 20706-20716. Date of Electronic Publication: 2020 Aug 06.
Autor:
Salgado C; Department of Dermatology, Leiden University Medical Center, Leiden., Kwesi-Maliepaard EM; Division of Gene Regulation, Netherlands Cancer Institute, Amsterdam., Jochemsen AG; Department of Cell and Chemical Biology, Leiden University Medical Center, Leiden, The Netherlands., Visser M; Department of Dermatology, Leiden University Medical Center, Leiden., Harland M; Section of Epidemiology and Biostatistics, Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, UK., van Leeuwen F; Division of Gene Regulation, Netherlands Cancer Institute, Amsterdam., van Doorn R; Department of Dermatology, Leiden University Medical Center, Leiden., Gruis N; Department of Dermatology, Leiden University Medical Center, Leiden.
Publikováno v:
Melanoma research [Melanoma Res] 2019 Dec; Vol. 29 (6), pp. 582-589.
Autor:
Vlaming H; Division of Gene Regulation, Netherlands Cancer Institute, Amsterdam, The Netherlands., McLean CM; Division of Gene Regulation, Netherlands Cancer Institute, Amsterdam, The Netherlands., Korthout T; Division of Gene Regulation, Netherlands Cancer Institute, Amsterdam, The Netherlands., Alemdehy MF; Division of Tumor Biology & Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Hendriks S; Division of Gene Regulation, Netherlands Cancer Institute, Amsterdam, The Netherlands., Lancini C; Division of Gene Regulation, Netherlands Cancer Institute, Amsterdam, The Netherlands., Palit S; Division of Gene Regulation, Netherlands Cancer Institute, Amsterdam, The Netherlands., Klarenbeek S; Experimental Animal Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Kwesi-Maliepaard EM; Division of Gene Regulation, Netherlands Cancer Institute, Amsterdam, The Netherlands., Molenaar TM; Division of Gene Regulation, Netherlands Cancer Institute, Amsterdam, The Netherlands., Hoekman L; Experimental Animal Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Schmidlin TT; Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research, Utrecht Institute for Pharmaceutical Sciences, Utrecht University and Netherlands Proteomics Centre, Utrecht, The Netherlands., Altelaar AM; Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research, Utrecht Institute for Pharmaceutical Sciences, Utrecht University and Netherlands Proteomics Centre, Utrecht, The Netherlands.; Proteomics Facility, Netherlands Cancer Institute, Amsterdam, The Netherlands., van Welsem T; Division of Gene Regulation, Netherlands Cancer Institute, Amsterdam, The Netherlands., Dannenberg JH; Division of Gene Regulation, Netherlands Cancer Institute, Amsterdam, The Netherlands., Jacobs H; Division of Tumor Biology & Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands., van Leeuwen F; Division of Gene Regulation, Netherlands Cancer Institute, Amsterdam, The Netherlands.
Publikováno v:
The EMBO journal [EMBO J] 2019 Jul 15; Vol. 38 (14), pp. e101564. Date of Electronic Publication: 2019 Jun 17.
Autor:
Peres J; Division of Cell Biology, Department of Human Biology, Faculty of Health Sciences, University of Cape Town, Observatory, 7925, Cape Town, South Africa. Electronic address: jade.peres@uct.ac.za., Kwesi-Maliepaard EM; Division of Cell Biology, Department of Human Biology, Faculty of Health Sciences, University of Cape Town, Observatory, 7925, Cape Town, South Africa. Electronic address: elizamarimaliepaard@gmail.com., Rambow F; VIB Center for Cancer Biology, Department of Oncology, Laboratory of Molecular Cancer Biology, Campus Gasthuisberg, O&N4, Herestraat 49 Box 602, 3000 Leuven, Belgium. Electronic address: florian.rambow@cme.vib-kuleuven.be., Larue L; Institut Curie, Normal and Pathological Development of Melanocytes, 91405 Orsay, France; Centre National de la Recherche Scientifique (CNRS) UMR3347, 91405 Orsay, France; INSERM U1021, 91405 Orsay, France; Equipe Labellisée - Ligue Nationale contre le Cancer, 91405 Orsay, France. Electronic address: lionel.larue@curie.fr., Prince S; Division of Cell Biology, Department of Human Biology, Faculty of Health Sciences, University of Cape Town, Observatory, 7925, Cape Town, South Africa. Electronic address: sharon.prince@uct.ac.za.
Publikováno v:
Cancer letters [Cancer Lett] 2017 Oct 01; Vol. 405, pp. 111-119. Date of Electronic Publication: 2017 Jul 28.